CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −6,100 | $31.28 | $191K | 41,384 |
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −483 | $31.79 | $15K | 40,901 |
| 2026-03-18 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −103 | $32.85 | $3K | 40,798 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | −2,173 | $31.28 | $68K | 10,381 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | −172 | $31.79 | $5K | 10,209 |
| 2026-03-18 | Leggett Thomas Chief Financial Officer | Sale | −37 | $32.85 | $1K | 10,172 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −1,762 | $31.28 | $55K | 10,445 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −139 | $31.79 | $4K | 10,306 |
| 2026-03-18 | Hoitt Jason Chief Patient Officer | Sale | −30 | $32.85 | $986 | 10,276 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −2,476 | $32.74 | $81K | 35,255 |
| 2026-03-17 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | −1,791 | $33.38 | $60K | 33,464 |
| 2026-03-17 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −3,577 | $32.74 | $117K | 50,071 |
| 2026-03-17 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −2,587 | $33.38 | $86K | 47,484 |
| 2026-03-17 | Leggett Thomas Chief Financial Officer | Sale | −1,274 | $32.74 | $42K | 13,476 |
| 2026-03-17 | Leggett Thomas Chief Financial Officer | Sale | −922 | $33.38 | $31K | 12,554 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | −1,033 | $32.74 | $34K | 12,955 |
| 2026-03-17 | Hoitt Jason Chief Patient Officer | Sale | −748 | $33.38 | $25K | 12,207 |
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +7,475 | 19,731 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +6,000 | 25,731 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise | +12,000 | 37,731 |
Page 4 of 13 · 256 trades